ABVC — ABVC Biopharma Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for ABVC Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	C2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-10.6	-12	-16.3	-8.28	-5.26
Depreciation
Deferred Taxes
Non-Cash Items	6.3	5.22	7.39	3.53	3.83
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.086	-1.61	0.636	0.422	-0.41
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-4.56	-7.6	-7.4	-4.19	-1.81
Capital Expenditures	—	-0.018	-0.12	-0.021	0
Purchase of Fixed Assets
Other Investing Cash Flow Items	-0.225	-0.788	-1.6	-0.339	0
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-0.225	-0.806	-1.72	-0.36	0
Financing Cash Flow Items	—	-0.85	0	-0.049	0.63
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	9.57	10	4.01	3.87	1.98
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	4.84	1.56	-5.17	-0.675	0.147